Dysregulated Myc expression is observed in many types of cancer, in line with the known role of this transcription factor in regulating cellular processes such as apoptosis, proliferation and differentiation. Investigating the function of Myc in diverse biological models provides clues to its role in cancer. Menescal et al. analyse a newly identified, unusual version of Myc (myc17) found in the medaka genome, which also contains a conventional, conserved version of Myc (myc20). Although Myc17 lacks protein-regulatory sequences found in other reported versions of Myc, studies of two inducible transgenic medaka lines show that Myc17 is functional and, like other versions of Myc, drives apoptosis and proliferation in vivo. In addition, long-term myc17 induction causes liver hyperplasia. These transgenic medaka lines can be further used to probe the role of Myc in liver tumorigenesis. Page 492
Newly identified medaka myc17 gene induces liver hyperplasia
Newly identified medaka myc17 gene induces liver hyperplasia. Dis Model Mech 1 July 2012; 5 (4): 413–414. doi:
Download citation file:
Advertisement
Cited by
History of our journals

As our publisher, The Company of Biologists, turns 100 years old, read about DMM’s history and explore the journey of each of our sister journals: Development, Journal of Cell Science, Journal of Experimental Biology and Biology Open.
A new perspective on disease research
DMM publishes perspectives – peer-reviewed articles that provide expert analysis of a topic important to the disease research community. Read our collection from authors presenting new or potentially controversial ideas or hypotheses, to help address future challenges and forge new directions.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
About us
Other journals from
The Company of Biologists